Statin-associated Exacerbation of Myasthenia Gravis

Neurology. 2004 Dec 14;63(11):2188. doi: 10.1212/01.wnl.0000145708.03876.c3.

Publication types

  • Case Reports

MeSH terms

  • Atorvastatin
  • Cytokines / biosynthesis
  • Cytokines / metabolism
  • Dysarthria / chemically induced*
  • Heptanoic Acids / adverse effects*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hyperlipidemias / complications
  • Hyperlipidemias / drug therapy
  • Hypertension / complications
  • Lovastatin / adverse effects
  • Male
  • Middle Aged
  • Mitochondria / drug effects
  • Models, Neurological
  • Muscular Diseases / chemically induced
  • Myasthenia Gravis / chemically induced*
  • Myasthenia Gravis / complications
  • Myasthenia Gravis / diagnosis
  • Myasthenia Gravis / drug therapy
  • Neural Conduction
  • Pravastatin / adverse effects
  • Pyridostigmine Bromide / therapeutic use
  • Pyrroles / adverse effects*
  • Simvastatin / adverse effects
  • Th2 Cells / metabolism
  • Ubiquinone / deficiency

Substances

  • Cytokines
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Ubiquinone
  • Lovastatin
  • Atorvastatin
  • Simvastatin
  • Pyridostigmine Bromide
  • Pravastatin